Evidence 1
Activity
Activity
0% Hemolysis
Toxicity
>500 µg/mL
Hemolytic
Cytotoxic
0% Hemolysis | >500 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide | Int J Microbiol | 2012